Sintilimab plus GemOx is an effective salvage therapy in patients with refractory⁄relapsing nodal peripheral T cell lymphomas
Preprint in Research Square (March 2024)
The most recent citing publications are shown below. View all 45 publications that cite this research output on Dimensions.
Preprint in Research Square (March 2024)
Preprint in Research Square (February 2024)
Article in Blood Advances (January 2024)